THU-151 - Results of the Phase II randomized French trial PRODIGE 21 comparing sorafenib vs pravastatin vs sorafenib and pravastatin vs best supportive care for the palliative treatment of HCC in CHILD B cirrhotic patients
| Autor: | Blanc, J.-F., Khemissa, F., Bronowicki, J.-P., Monterymard, C., Perarnau, J.-M., Bourgeois, V., Obled, S., Abdelghani, M.B., Mabile-Archambeaud, I., Faroux, R., Seitz, J.-F., Locher, C., Senellart, H., Villing, A.-L., Audemar, F., Costentin, C., Delplanque, G., Manfredi, S., Edeline, J. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2018 68 Supplement 1:S195-S195 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect